Engineering proteins to tackle life-threatening diseases with an eye on accessibility.
Proteinea makes biotherapeutics design smarter, safer, and faster by leveraging novel deep-learning models & platforms integrated with smart experimental throughput.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2020 | Convertable Note | — | 1 | 500 Global | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
500 Global | Yes | Convertable Note |